METYRAPONE Side Effects

6769816-0 | Acth-producing Pituitary Tumour, Malaise, Pneumonia Staphylococcal, Septic Shock, Staphylococcal Sepsis
on May 18, 2010 Female patient from JAPAN , 68 years of age, weighting 138.9 lb, was treated with Metyrapone (View Usage). Patient experienced the following unwanted or unexpected effects: acth-producing pituitary tumour, malaise, pneumonia staphylococcal, septic shock, staphylococcal sepsis. Metyrapone dosage: 1500 Mg, Unk.

6464185-8 | Adrenal Insufficiency, Circulatory Collapse, Granulocytopenia, Leukopenia, Neutropenia, Red Blood Cell Nucleated Morphology Present
Patient was taking Metyrapone (View Usage). Patient had the following side effects: adrenal insufficiency, circulatory collapse, granulocytopenia, leukopenia, neutropenia, red blood cell nucleated morphology present on Nov 11, 2009 from UNITED STATES Additional patient health information: Female patient , 62 years of age, . Metyrapone dosage: 750 Mg, Q6h. During the same period patient was treated with KETOCONAZOLE (600 Mg, Bid) (View Ketoconazole Review and Ketoconazole Label ). Patient was hospitalized.

6170502-9 | Adrenocortical Insufficiency Acute
Adverse event was reported on Apr 27, 2009 by a Female patient taking Metyrapone (View Usage) (Dosage: 750 Mg Po Q 6) was diagnosed with pituitary-dependent cushing's syndrome and. Location: UNITED STATES , 62 years of age, weighting 163.1 lb, After Metyrapone was administered, patient had the following side effects: adrenocortical insufficiency acute. During the same period patient was treated with KETOCONAZOLE (View Ketoconazole Review and Ketoconazole Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), INSULATARD NPH HUMAN (View Insulatard Nph Human Review and Insulatard Nph Human Label ).

5490397-6 | Anorexia, Bacterial Infection, Blood Beta-d-glucan Increased, Hypoalbuminaemia, Lung Infiltration, Malaise, Oedema Peripheral, Pneumocystis Jiroveci Pneumonia, Po2 Decreased
on Oct 10, 2007 Female patient from JAPAN , 82 years of age, weighting 166.9 lb, was diagnosed with pituitary-dependent cushing's syndrome and was treated with Metyrapone (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, bacterial infection (What is bacterial infection?), blood beta-d-glucan increased, hypoalbuminaemia, lung infiltration, malaise, oedema peripheral, pneumocystis jiroveci pneumonia, po2 decreased. Metyrapone dosage: 750 Mg/d. During the same period patient was treated with HYDROCORTISONE (10 Mg, Qd) (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.


5440785-9 | Blood Corticotrophin Increased, Cortisol Free Urine Increased, Cushingoid, Hyperadrenalism, Hypertension, Pituitary Tumour Benign, Pituitary Tumour Removal, Pituitary-dependent Cushing's Syndrome
on Aug 21, 2007 Female patient from JAPAN , 66 years of age, weighting 130.5 lb, was diagnosed with pituitary-dependent cushing's syndrome, diabetes mellitus, hypertension and was treated with Metyrapone (View Usage). Patient had the following side effects: blood corticotrophin increased, cortisol free urine increased, cushingoid, hyperadrenalism, hypertension, pituitary tumour benign, pituitary tumour removal, pituitary-dependent cushing's syndrome. Metyrapone dosage: 1250 Mg/d. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), AMLODIPINE (2.5 Mg/d) (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

4999388-2 | Neonatal Respiratory Distress Syndrome, Premature Baby
Patient was taking Metyrapone (View Usage). After Metyrapone was administered, patient had the following side effects: neonatal respiratory distress syndrome, premature baby on Apr 28, 2006 from SPAIN Additional patient health information: Male patient , weighting 2822 lb, . Metyrapone dosage: . During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ).

4999387-0 | Adrenalectomy, Premature Labour, Premature Rupture Of Membranes
Adverse event was reported on Apr 28, 2006 by a Female patient taking Metyrapone (View Usage) (Dosage: 750 G/d) was diagnosed with hypercorticoidism and. Location: SPAIN , 30 years of age, Patient experienced the following unwanted or unexpected effects: adrenalectomy, premature labour, premature rupture of membranes. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).